A detailed history of Amundi transactions in Organon & Co. stock. As of the latest transaction made, Amundi holds 448,837 shares of OGN stock, worth $6.61 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
448,837
Previous 508,182 11.68%
Holding current value
$6.61 Million
Previous $10.5 Million 18.38%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$18.65 - $23.03 $1.11 Million - $1.37 Million
-59,345 Reduced 11.68%
448,837 $8.59 Million
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $6.84 Million - $8.6 Million
391,790 Added 336.61%
508,182 $10.5 Million
Q1 2024

May 15, 2024

SELL
$13.78 - $18.8 $18,727 - $25,549
-1,359 Reduced 1.15%
116,392 $2.19 Million
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $25.8 Million - $40.9 Million
-2,359,015 Reduced 95.25%
117,751 $1.7 Million
Q3 2023

Nov 14, 2023

SELL
$16.59 - $23.77 $38.8 Million - $55.6 Million
-2,340,782 Reduced 48.59%
2,476,766 $43 Million
Q2 2023

Aug 14, 2023

BUY
$19.27 - $24.63 $1.76 Million - $2.25 Million
91,447 Added 1.93%
4,817,548 $100 Million
Q1 2023

May 15, 2023

BUY
$21.42 - $32.08 $28.2 Million - $42.3 Million
1,318,768 Added 38.7%
4,726,101 $111 Million
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $39.5 Million - $48.5 Million
1,693,968 Added 98.87%
3,407,333 $95.2 Million
Q3 2022

Nov 14, 2022

BUY
$23.4 - $34.25 $7.31 Million - $10.7 Million
312,410 Added 22.3%
1,713,365 $43.9 Million
Q2 2022

Aug 15, 2022

BUY
$31.66 - $38.9 $1.48 Million - $1.82 Million
46,731 Added 3.45%
1,400,955 $44.6 Million
Q1 2022

May 16, 2022

BUY
$30.45 - $39.36 $10.7 Million - $13.8 Million
351,585 Added 35.07%
1,354,224 $49 Million
Q4 2021

Feb 14, 2022

BUY
$28.67 - $37.13 $4.31 Million - $5.59 Million
150,431 Added 17.65%
1,002,639 $33 Million
Q3 2021

Nov 15, 2021

BUY
$28.63 - $35.64 $24.4 Million - $30.4 Million
852,208 New
852,208 $27.9 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.75B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Amundi Portfolio

Follow Amundi and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.